BriaCell Therapeutics (BCT) News Today → “This will be one of the biggest revolutions ever.” - NVIDIA CEO (From Behind the Markets) (Ad) Free BCT Stock Alerts C$10.60 -0.42 (-3.81%) (As of 12/30/2021) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative February 29, 2024 | ca.finance.yahoo.comBriaCell Therapeutics Corp. (BCT.TO)February 7, 2024 | msn.comBriaCell shares rise on strong data from breast cancer treatment studyFebruary 7, 2024 | markets.businessinsider.comBriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseFebruary 6, 2024 | marketwatch.comBriaCell Shares Advance as Production of Lead Candidate BeginsDecember 28, 2023 | finanznachrichten.deBriaCell Therapeutics Corp.: BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsDecember 28, 2023 | markets.businessinsider.comBriaCell's Bria-IMT Regimen Shows 71% Intracranial ORR In Breast Cancer PatientsDecember 20, 2023 | markets.businessinsider.comBriaCell Therapeutics Reports Preliminary Survival Benefit Data In Bria-IMT RegimenDecember 1, 2023 | finance.yahoo.comHere's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn SituationNovember 3, 2023 | finance.yahoo.comBriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDOctober 18, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp flat on Tuesday (BCT)October 6, 2023 | stockhouse.comBriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT(TM) in Advanced Breast CancerOctober 3, 2023 | finance.yahoo.comBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in Advanced Metastatic Breast CancerSeptember 27, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Tuesday (BCT)September 8, 2023 | markets.businessinsider.comBriaCell Therapeutics (BCT) Initiated with a Buy at H.C. WainwrightAugust 17, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)August 16, 2023 | finance.yahoo.comBriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS™ Immunotherapy for CancerMay 30, 2023 | finance.yahoo.comBriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDailyMay 25, 2023 | finanznachrichten.deBriaCell Therapeutics Corp.: BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp.May 6, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Friday (BCT)April 26, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Tuesday (BCT)April 25, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Monday (BCT)April 21, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Thursday (BCT)April 17, 2023 | baystreet.caPositive Developments for Breast Cancer Care Attracting Big Investor AttentionApril 15, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Friday (BCT)April 13, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Wednesday (BCT)April 11, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Monday (BCT)March 30, 2023 | finance.yahoo.comBriaCell Announces Intention to Spin-Out Certain Pre-Clinical Assets into a Newly Created “SpinCo” Entity whereby Shareholders to Receive One New Share of “SpinCo” in Addition to Each Current Share of BriaCell Already HeldMarch 14, 2023 | baystreet.caBreast Cancer Treatment Options Evolved Over the Last 12 Months, Bringing More Hope for 2023February 11, 2023 | finance.yahoo.comBriaCell Therapeutics Corp. (TSE:BCT) most popular amongst individual investors who own 59%, insiders hold 14%January 24, 2023 | finance.yahoo.comBriaCell CEO Letter to ShareholdersJanuary 23, 2023 | finance.yahoo.comBriaCell to investigate alleged illegal trading activity by outsidersJanuary 23, 2023 | finance.yahoo.comBriaCell to Investigate Alleged Illegal Trading of Public SecuritiesJanuary 18, 2023 | finance.yahoo.comBriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT™ Combination in Advanced Metastatic Breast CancerDecember 2, 2022 | finance.yahoo.comBriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer PatientsNovember 21, 2022 | finance.yahoo.comBCTX: SITC Poster PresentationNovember 15, 2022 | finance.yahoo.comBriaCell CEO Discusses Positive Clinical Results of its Breast Cancer Immunotherapy Treatment in an Audio Interview with SmallCapVoice.comSeptember 28, 2022 | finance.yahoo.comBriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7thSeptember 14, 2022 | finance.yahoo.comBriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular ProfilingSeptember 7, 2022 | finance.yahoo.comBriaCell Announces Presentation at the 2022 Society for Immunotherapy of Cancer (SITC) Annual MeetingJune 23, 2022 | finance.yahoo.comBCTX: New Sites Expand Bria-IMT TrialJune 13, 2022 | theglobeandmail.comCreatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 DaysApril 13, 2022 | stockhouse.comBriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer ImmunotherapyApril 12, 2022 | stockhouse.comBriaCell Presents Development Details of Bria-OTS(TM) Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022April 12, 2022 | finance.yahoo.comBriaCell Presents Development Details of Bria-OTS™ Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022April 7, 2022 | stockhouse.comBriaCell advances preparatory work for new Bria-OTS(TM) breast cancer clinical trialApril 7, 2022 | finance.yahoo.comBriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trialMarch 29, 2022 | finance.yahoo.comBCTX: Second Quarter ResultsFebruary 11, 2022 | finance.yahoo.comBullish BriaCell Therapeutics Corp. (TSE:BCT) insiders were rewarded last week as their US$12m investment inflated to US$17mFebruary 10, 2022 | ca.finance.yahoo.comStocks in play: BriaCell Therapeutics CorpJanuary 11, 2022 | finance.yahoo.comTMX Group Equity Financing Statistics - December 2021 Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address “This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it. A new breakthrough tech could add up to $20 trillion to the U.S. economy. BCT Media Mentions By Week BCT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCT News Sentiment▼0.000.79▲Average Medical News Sentiment BCT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCT Articles This Week▼00▲BCT Articles Average Week Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Medicenna Therapeutics News Oncolytics Biotech News Sernova News Theratechnologies News Fennec Pharmaceuticals News ProMIS Neurosciences News Small Pharma News Microbix Biosystems News Zentek News Quipt Home Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:BCT) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
